Trials / Completed
CompletedNCT00684424
Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
Non-Interventional Study (NIS) With Lyrica In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 199 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary efficacy parameter will be the responder rate, defined as the proportion of subjects who had at least a 50% reduction in 28 day seizure rate during the maintenance phase
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Observational Only |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2008-05-26
- Last updated
- 2021-02-10
- Results posted
- 2010-06-24
Source: ClinicalTrials.gov record NCT00684424. Inclusion in this directory is not an endorsement.